TAKEDA PHARMACEUTICAL COMPANY LIMITED

(4502)
  Report
Delayed Japan Exchange  -  02:00 2022-07-01 am EDT
3759.00 JPY   -1.55%
07/01Takeda's Takhzyro Shows 94.8% Reduction in Hereditary Angioedema Attacks in Phase 3 Trial in Children
MT
06/30TAKEDA PHARMACEUTICAL : Phase 3 SPRING study data presented at EAACI
PU
06/30Takeda's TAKHZYRO® (lanadelumab) Demonstrated Positive Results in the Prevention of HAE Attacks in First and Only Open-Label Phase 3 Trial in Children Ages 2 to <12 Years
BU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about TAKEDA PHARMACEUTICAL COMPANY LIMITED
07/01Takeda's Takhzyro Shows 94.8% Reduction in Hereditary Angioedema Attacks in Phase 3 Tri..
MT
06/30TAKEDA PHARMACEUTICAL : Phase 3 SPRING study data presented at EAACI
PU
06/30Takeda's TAKHZYRO® (lanadelumab) Demonstrated Positive Results in the Prevention of HAE..
BU
06/30Takeda Pharmaceutical Company Limited Demonstrates Positive Results in the Prevention o..
CI
06/29TAKEDA PHARMACEUTICAL : Executive compensation overview
PU
06/29TAKEDA PHARMACEUTICAL : Announces the Publication of its Annual Report on Form 20-F for FY..
PU
06/29TAKEDA PHARMACEUTICAL : ARTICLES OF INCORPORATION OF TAKEDA PHARMACEUTICAL COMPANY LIMITED..
PU
06/29TAKEDA PHARMACEUTICAL : Announces New Assignments of Directors - Form 6-K
PU
06/29Takeda Pharmaceutical Company Limited Announces New Assignments of Directors
CI
06/29Takeda Pharmaceutical Company Limited Approves Dividend for the Year Ended March 31, 20..
CI
06/29Takeda Pharmaceutical Company Limited Announces Board Appointments
CI
06/29TAKEDA PHARMACEUTICAL : Announces New Assignments of Directors
PU
06/28Takeda - Results from Phase 2 Study of Fazirsiran in Patients with Alpha-1 Antitrypsin ..
AQ
06/27Results from Phase 2 Study of Fazirsiran in Patients with Alpha-1 Antitrypsin Deficienc..
BU
06/27Takeda and Arrowhead Announce Results from Phase 2 Study of Fazirsiran in Patients with..
CI
More most relevant news
All news about TAKEDA PHARMACEUTICAL COMPANY LIMITED
07/01Takeda's Takhzyro Shows 94.8% Reduction in Hereditary Angioedema Attacks in Phase 3 Tri..
MT
06/30TAKEDA PHARMACEUTICAL : Phase 3 SPRING study data presented at EAACI
PU
06/30Takeda's TAKHZYRO® (lanadelumab) Demonstrated Positive Results in the Prevention of HAE..
BU
06/30Takeda Pharmaceutical Company Limited Demonstrates Positive Results in the Prevention o..
CI
06/29TAKEDA PHARMACEUTICAL : Executive compensation overview
PU
06/29TAKEDA PHARMACEUTICAL : Announces the Publication of its Annual Report on Form 20-F for FY..
PU
06/29TAKEDA PHARMACEUTICAL : ARTICLES OF INCORPORATION OF TAKEDA PHARMACEUTICAL COMPANY LIMITED..
PU
06/29TAKEDA PHARMACEUTICAL : Announces New Assignments of Directors - Form 6-K
PU
06/29Takeda Pharmaceutical Company Limited Announces New Assignments of Directors
CI
06/29Takeda Pharmaceutical Company Limited Approves Dividend for the Year Ended March 31, 20..
CI
More news
News in other languages on TAKEDA PHARMACEUTICAL COMPANY LIMITED
07/01Le Takhzyro de Takeda montre une réduction de 94,8% des crises d'angioedème héréditaire..
06/30Takeda Pharmaceutical Company Limited démontre des résultats positifs dans la préventio..
06/29Takeda Pharmaceutical Company Limited annonce de nouvelles affectations de ses directeu..
06/29Takeda Pharmaceutical Company Limited annonce des nominations au conseil d'administrati..
06/29Takeda Pharmaceutical Company Limited approuve un dividende pour l'exercice clos le 31 ..
06/27The New England Journal of Medicine publica los resultados del estudio de fase 2 de faz..
06/27Takeda et Arrowhead annoncent les résultats de l'étude de phase 2 du Fazirsiran chez le..
06/22Takeda signe un bail de 15 ans avec BioMed Realty
06/17NOMINATIONS, FAIBLESSE DU YEN, INFLA : Planète Bourse du vendredi 17 juin 2022
06/09La vacuna candidata de Takeda contra el dengue ofrece protección contra esta enfermedad..
More news
Analyst Recommendations on TAKEDA PHARMACEUTICAL COMPANY LIMITED
2021TAKEDA PHARMACEUTICAL : Morgan Stanley Downgrades Takeda Pharmaceutical to Equal-weight Fr..
MT
2020TAKEDA PHARMACEUTICAL : Japan's Takeda says drug pipeline to lift sales to $48 billion in ..
RE
2018Takeda clears key hurdle as investors back $59 billion Shire deal
RE
2018Takeda investors back $59 billion Shire deal, but wary of debt load
RE
2018Takeda shareholders bin proposal from anti-Shire group; only 10 percent in favour
RE
More recommendations
Press releases
06/30TAKEDA PHARMACEUTICAL : Phase 3 SPRING study data presented at EAACI
PU
06/30Takeda's TAKHZYRO® (lanadelumab) Demonstrated Positive Results in the Prevention of HAE..
BU
06/29TAKEDA PHARMACEUTICAL : Executive compensation overview
PU
06/29TAKEDA PHARMACEUTICAL : Announces the Publication of its Annual Report on Form 20-F for FY..
PU
06/29TAKEDA PHARMACEUTICAL : ARTICLES OF INCORPORATION OF TAKEDA PHARMACEUTICAL COMPANY LIMITED..
PU
More press releases
Upcoming event on TAKEDA PHARMACEUTICAL COMPANY LIMITED